Young adult daughters of <i>BRCA1/2</i> positive mothers: What do they know about hereditary cancer and how much do they worry?

Abstract

Targeted professional attention to this high-risk cohort of young women is critical to inform the next generation of daughters of BRCA1/2 mutation carriers and encourage recommended screening by age 25 years. Improved uptake of screening and risk reduction options could improve survival, and psychoeducation could reduce cancer-related distress.